GPC Biotech at a Glance
GPC Biotech AG is a publicly traded biopharmaceutical company focused on anticancer drugs.
GPC Biotech's lead product candidate is satraplatin, an oral platinum compound.
The Company has various anti-cancer programs in research and development that leverage its expertise in kinase inhibitors.
GPC Biotech AG is headquartered in Martinsried/Munich (Germany) and has a wholly owned U.S. subsidiary in Princeton, New Jersey.
